Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2031471rdf:typepubmed:Citationlld:pubmed
pubmed-article:2031471lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:2031471lifeskim:mentionsumls-concept:C0018674lld:lifeskim
pubmed-article:2031471lifeskim:mentionsumls-concept:C0021246lld:lifeskim
pubmed-article:2031471lifeskim:mentionsumls-concept:C0228174lld:lifeskim
pubmed-article:2031471lifeskim:mentionsumls-concept:C0373440lld:lifeskim
pubmed-article:2031471lifeskim:mentionsumls-concept:C0021880lld:lifeskim
pubmed-article:2031471lifeskim:mentionsumls-concept:C0025519lld:lifeskim
pubmed-article:2031471lifeskim:mentionsumls-concept:C0007818lld:lifeskim
pubmed-article:2031471lifeskim:mentionsumls-concept:C0151740lld:lifeskim
pubmed-article:2031471lifeskim:mentionsumls-concept:C0205082lld:lifeskim
pubmed-article:2031471lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:2031471lifeskim:mentionsumls-concept:C0428714lld:lifeskim
pubmed-article:2031471pubmed:issue3-4lld:pubmed
pubmed-article:2031471pubmed:dateCreated1991-6-20lld:pubmed
pubmed-article:2031471pubmed:abstractTextIn five head-injured patients with cerebral contusion and oedema in whom it was not possible to control intracranial pressure (ICP) (ICP greater than 20 mmHg) by artificial hyperventilation (PaCO2 level 3.5-4.0 kPa) and barbiturate sedation, indomethacin was used as a vasoconstrictor drug. In all patients, indomethacin (a bolus injection of 30 mg, followed by 30 mg/h for seven hours) reduced ICP below 20 mmHg for several hours. Studies of cerebral circulation and metabolism during indomethacin treatment showed a decrease in CBF at 2 h. After 7 h, ICP remained below 20 mmHg in three patients, and these still had reduced CBF. In the other patients a return of ICP and CBF to pretreatment levels was observed. In all patients indomethacin treatment was followed by a fall in rectal temperature. These results suggest that indomethacin due to its cerebral vasoconstrictor and antipyretic effect should be considered as an alternative for treatment of ICP-hypertension in head-injured patients.lld:pubmed
pubmed-article:2031471pubmed:languageenglld:pubmed
pubmed-article:2031471pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2031471pubmed:citationSubsetIMlld:pubmed
pubmed-article:2031471pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2031471pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2031471pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2031471pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2031471pubmed:statusMEDLINElld:pubmed
pubmed-article:2031471pubmed:issn0001-6268lld:pubmed
pubmed-article:2031471pubmed:authorpubmed-author:JensenKKlld:pubmed
pubmed-article:2031471pubmed:authorpubmed-author:AstrupJJlld:pubmed
pubmed-article:2031471pubmed:authorpubmed-author:ColdG EGElld:pubmed
pubmed-article:2031471pubmed:authorpubmed-author:OhrströmJJlld:pubmed
pubmed-article:2031471pubmed:issnTypePrintlld:pubmed
pubmed-article:2031471pubmed:volume108lld:pubmed
pubmed-article:2031471pubmed:ownerNLMlld:pubmed
pubmed-article:2031471pubmed:authorsCompleteYlld:pubmed
pubmed-article:2031471pubmed:pagination116-21lld:pubmed
pubmed-article:2031471pubmed:dateRevised2009-11-11lld:pubmed
pubmed-article:2031471pubmed:meshHeadingpubmed-meshheading:2031471-...lld:pubmed
pubmed-article:2031471pubmed:meshHeadingpubmed-meshheading:2031471-...lld:pubmed
pubmed-article:2031471pubmed:meshHeadingpubmed-meshheading:2031471-...lld:pubmed
pubmed-article:2031471pubmed:meshHeadingpubmed-meshheading:2031471-...lld:pubmed
pubmed-article:2031471pubmed:meshHeadingpubmed-meshheading:2031471-...lld:pubmed
pubmed-article:2031471pubmed:meshHeadingpubmed-meshheading:2031471-...lld:pubmed
pubmed-article:2031471pubmed:meshHeadingpubmed-meshheading:2031471-...lld:pubmed
pubmed-article:2031471pubmed:meshHeadingpubmed-meshheading:2031471-...lld:pubmed
pubmed-article:2031471pubmed:meshHeadingpubmed-meshheading:2031471-...lld:pubmed
pubmed-article:2031471pubmed:meshHeadingpubmed-meshheading:2031471-...lld:pubmed
pubmed-article:2031471pubmed:meshHeadingpubmed-meshheading:2031471-...lld:pubmed
pubmed-article:2031471pubmed:meshHeadingpubmed-meshheading:2031471-...lld:pubmed
pubmed-article:2031471pubmed:meshHeadingpubmed-meshheading:2031471-...lld:pubmed
pubmed-article:2031471pubmed:meshHeadingpubmed-meshheading:2031471-...lld:pubmed
pubmed-article:2031471pubmed:meshHeadingpubmed-meshheading:2031471-...lld:pubmed
pubmed-article:2031471pubmed:meshHeadingpubmed-meshheading:2031471-...lld:pubmed
pubmed-article:2031471pubmed:meshHeadingpubmed-meshheading:2031471-...lld:pubmed
pubmed-article:2031471pubmed:meshHeadingpubmed-meshheading:2031471-...lld:pubmed
pubmed-article:2031471pubmed:year1991lld:pubmed
pubmed-article:2031471pubmed:articleTitleThe effects of indomethacin on intracranial pressure, cerebral blood flow and cerebral metabolism in patients with severe head injury and intracranial hypertension.lld:pubmed
pubmed-article:2031471pubmed:affiliationDepartment of Neuroanaesthesia, Arhus Kommunehospital, Denmark.lld:pubmed
pubmed-article:2031471pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2031471lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2031471lld:pubmed